NIH-funded research shows prenatal PFAS exposure increases maternal beta-cell dysfunction risk by 15-20% a decade postpartum, with epigenetic changes as a key mechanism. Emerging evidence connects pre...
Recent research shows prenatal PFAS exposure correlates with beta cell dysfunction and metabolic disorders, prompting calls for stricter regulations and exposure reduction strategies. Emerging studies...
New research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by 30%, with long-term metabolic consequences. Emerging evidence reveals PFAS chemi...
